Diabetic Retinopathy and Glucagon-Like Peptide 1 Agonists Previous studies, including the DCCT, SUSTAIN-6, LEADER and TECOS trials, have linked exposure to incretin-based therapies and other hypoglycemic agents (i.e., insulin , injectable semaglutide, liraglutide , and oral sitagliptin ) to the exacerbation of pre-existing retinopathy (Diabetes Control and Complications Trial Research Group, Nathan et al., 1993
J Neurol Neurosurg Psychiatry 2005
Most recently, the high abundance of a delta GST, SzeaGSTd1 in Sitophilus zeamais antennae, inhibition of SzeaGSTd1 catalytic activity by capryl alcohol, along with the degradation of capryl alcohol by recombinant SzeaGSTd1 were observed [110]
Talk to a qualified clinician before starting any injection
Both medications helped people lose weight and improve other weight-related conditions